[HTML][HTML] Current scenario of hepatitis B and its treatment in India

G Ray - Journal of clinical and translational hepatology, 2017 - ncbi.nlm.nih.gov
Hepatitis B is a significant public health problem in India, yet disease awareness is very low
among the general population. The disease is mostly acquired horizontally, but the role of …

Nucleos (t) ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis

JS Geng, HN Bao, YL Chen, LL Shi… - Expert Review of Anti …, 2020 - Taylor & Francis
ABSTRACT Objectives Chronic hepatitis B (CHB) is a major global health problem caused
by hepatitis B virus (HBV) infection, and can put patients at high risk of death from cirrhosis …

Chronic hepatitis B: correlation of abnormal features on T2-weighted imaging and dynamic contrast-enhanced imaging with hepatic histopathology

J Shu, JN Zhao, FG Han, GC Tang, X Chen - La radiologia medica, 2017 - Springer
Objectives To investigate the correlations between abnormal features on liver magnetic
resonance (MR) T2-weighted imaging (T2WI) and dynamic contrast-enhanced (DCE) …

Alteration of the ERK5 pathway by hydroxysafflor yellow A blocks expression of MEF2C in activated hepatic stellate cells in vitro: Potential treatment for hepatic …

H Dong, Y Liu, Y Zou, C Li, L Li, X Li, X Zhao… - Pharmaceutical …, 2014 - Taylor & Francis
Context: Hepatic fibrosis ultimately leads to cirrhosis if not treated effectively. Hepatic stellate
cells (HSC) are a main mediator of hepatic fibrosis through the accumulation of extracellular …

[PDF][PDF] 肝癌术后抗乙型肝炎病毒治疗对预防肝癌复发的研究

周运添, 谢建明, 黄婷娘, 林俊平 - 实用临床医药杂志, 2011 - jcmp.yzu.edu.cn
目的探讨肝癌手术后抗乙型肝炎病毒(mV) 治疗对预防肝癌复发的效果及影响. 方法将20
例并发乙型肝癌病毒复制的肝癌患者随机分为两组: 对照组lO 例, 单纯接受了肝癌根治术; …

[HTML][HTML] 乙型肝炎肝衰竭患者发生肝性脑病的影响因素

潘纯凯, 张延艳, 马伟 - 世界华人消化杂志, 2014 - wjgnet.com
乙型肝炎肝衰竭患者发生肝性脑病的影响因素 主页 简体中文 English 简体中文 登录 BPG
Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化杂志在线 …

HBV DNA 联合ALT 对HBeAg 阴性慢性活动性乙型肝炎的诊断价值

汪涛, 刘娟, 王婵, 朱武 - 中国中西医结合消化杂志, 2016 - whuhzzs.com
[目的] 探讨HBV DNA 联合ALT 对HBeAg 阴性慢性活动性乙型肝炎的诊断价值.[方法] 选取2014
年8 月~ 2015 年11 月于我院诊治的HBeAg 阴性慢性乙型肝炎患者320 例 …

[引用][C] 阿德福韦酯联合还原型谷胱甘肽对代偿期乙型肝炎后肝硬化患者肝功能和炎性因子水平的影响及其疗效分析

张雷, 戴一菲 - 海南医学院学报, 2015

[引用][C] 拉米夫定联合阿德福韦酯治疗失代偿期乙型肝炎肝硬化的疗效分析

万继红, 范海威, 段红岩 - 海南医学院学报, 2013

[引用][C] 拉米夫定联合阿德福韦酯治疗失代偿期乙型肝炎肝硬化临床疗效观察

薛扬 - 中国当代医药, 2012